Myraquat

Foundation date

14/04/2020

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Myraquat develops therapeutic compounds acting as membrane modulators to control pathogenic microorganisms.

Upcoming events

Latest news

  • Labconsort and NEKTARI join forces for a more sustainable and social industry

    Saturday April 20th 2024

  • BIO INX Complements Advisory Board with Distinguished Industry Leaders

    Thursday April 18th 2024

  • Innovating today, creating tomorrow: the VIB Bio-Incubator

    Thursday April 18th 2024